Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.

MLA

Dombi, Eva, et al. “Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.” The New England Journal of Medicine, vol. 375, no. 26, Dec. 2016, pp. 2550–60. EBSCOhost, https://doi.org/10.1056/NEJMoa1605943.

APA

Dombi, E., Baldwin, A., Marcus, L. J., Fisher, M. J., Weiss, B., Kim, A., Whitcomb, P., Martin, S., Aschbacher-Smith, L. E., Rizvi, T. A., Wu, J., Ershler, R., Wolters, P., Therrien, J., Glod, J., Belasco, J. B., Schorry, E., Brofferio, A., Starosta, A. J., … Widemann, B. C. (2016). Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas. The New England Journal of Medicine, 375(26), 2550–2560. https://doi.org/10.1056/NEJMoa1605943

Chicago

Dombi, Eva, Andrea Baldwin, Leigh J Marcus, Michael J Fisher, Brian Weiss, AeRang Kim, Patricia Whitcomb, et al. 2016. “Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.” The New England Journal of Medicine 375 (26): 2550–60. doi:10.1056/NEJMoa1605943.